LOCUS       NP_612200                339 aa                     PRI 19-APR-2014
DEFINITION  trace amine-associated receptor 1 [Homo sapiens].
ACCESSION   NP_612200
VERSION     NP_612200.1  GI:21264324
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 339)
  AUTHORS   Babusyte A, Kotthoff M, Fiedler J and Krautwurst D.
  TITLE     Biogenic amines activate blood leukocytes via trace amine-associated
            receptors TAAR1 and TAAR2
  JOURNAL   J. Leukoc. Biol. 93 (3), 387-394 (2013)
   PUBMED   23315425
  REMARK    GeneRIF: biogenic amines potently regulate blood cell functions via
            TAAR1 and TAAR2 and open the perspective of their specific
            pharmacological modulation.
REFERENCE   2  (residues 1 to 339)
  AUTHORS   Panas MW, Xie Z, Panas HN, Hoener MC, Vallender EJ and Miller GM.
  TITLE     Trace amine associated receptor 1 signaling in activated lymphocytes
  JOURNAL   J Neuroimmune Pharmacol 7 (4), 866-876 (2012)
   PUBMED   22038157
  REMARK    GeneRIF: an increase in TAAR1 receptor expression is concomitant
            with lymphocyte immune activation, suggesting a possible role for
            TAAR1 in the generation or regulation of an immune response
REFERENCE   3  (residues 1 to 339)
  AUTHORS   Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ and Miller GM.
  TITLE     Augmentation of methamphetamine-induced behaviors in transgenic mice
            lacking the trace amine-associated receptor 1
  JOURNAL   Pharmacol. Biochem. Behav. 101 (2), 201-207 (2012)
   PUBMED   22079347
  REMARK    GeneRIF: Methamphetamine-but not morphine-induced conditioned place
            preference was augmented in TAAR1 transgenic mice.
REFERENCE   4  (residues 1 to 339)
  AUTHORS   Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T,
            Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga
            S, De Montrion C, Rodriguez M, Galizzi JP, Lockhart BP, Coge F,
            Boutin JA, Vayer P, Verdouw PM, Groenink L and Millan MJ.
  TITLE     Genetic deletion of trace amine 1 receptors reveals their role in
            auto-inhibiting the actions of ecstasy (MDMA)
  JOURNAL   J. Neurosci. 31 (47), 16928-16940 (2011)
   PUBMED   22114263
  REMARK    GeneRIF: Trace amine 1 receptors (TA1R) exert an inhibitory
            influence on both dopaminergic and serotonergic transmission, and
            MDMA (ecstasy) auto-inhibits its neurochemical and functional
            actions by recruitment of TA1R.
REFERENCE   5  (residues 1 to 339)
  AUTHORS   Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS,
            Caron MG and Gainetdinov RR.
  TITLE     Functional interaction between trace amine-associated receptor 1 and
            dopamine D2 receptor
  JOURNAL   Mol. Pharmacol. 80 (3), 416-425 (2011)
   PUBMED   21670104
  REMARK    GeneRIF: data suggest that TAAR1 and D2R have functional and
            physical interactions that could be critical for the modulation of
            the dopaminergic system by TAAR1 in vivo
REFERENCE   6  (residues 1 to 339)
  AUTHORS   Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK and
            Hoener MC.
  TITLE     Trace amine-associated receptors form structurally and functionally
            distinct subfamilies of novel G protein-coupled receptors
  JOURNAL   Genomics 85 (3), 372-385 (2005)
   PUBMED   15718104
REFERENCE   7  (residues 1 to 339)
  AUTHORS   Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L,
            Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel
            G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell
            RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow
            KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S,
            Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W,
            Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee
            CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR,
            Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME,
            Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A,
            Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM,
            Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths
            C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA,
            Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR,
            Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA,
            Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor
            S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE,
            Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L,
            McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC,
            Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker
            A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW,
            Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra
            HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL,
            Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas
            DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West
            AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer
            TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR,
            Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J and
            Beck S.
  TITLE     The DNA sequence and analysis of human chromosome 6
  JOURNAL   Nature 425 (6960), 805-811 (2003)
   PUBMED   14574404
REFERENCE   8  (residues 1 to 339)
  AUTHORS   Feldman DS, Zamah AM, Pierce KL, Miller WE, Kelly F, Rapacciuolo A,
            Rockman HA, Koch WJ and Luttrell LM.
  TITLE     Selective inhibition of heterotrimeric Gs signaling. Targeting the
            receptor-G protein interface using a peptide minigene encoding the
            Galpha(s) carboxyl terminus
  JOURNAL   J. Biol. Chem. 277 (32), 28631-28640 (2002)
   PUBMED   12036966
REFERENCE   9  (residues 1 to 339)
  AUTHORS   Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley
            DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB,
            Magenis RE, Amara SG and Grandy DK.
  TITLE     Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid
            diethylamide, and metabolites of the catecholamine neurotransmitters
            are agonists of a rat trace amine receptor
  JOURNAL   Mol. Pharmacol. 60 (6), 1181-1188 (2001)
   PUBMED   11723224
REFERENCE   10  (residues 1 to 339)
  AUTHORS   Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL,
            Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X,
            Kouranova E, Lichtblau H, Ochoa FY, Branchek TA and Gerald C.
  TITLE     Trace amines: identification of a family of mammalian G
            protein-coupled receptors
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 98 (16), 8966-8971 (2001)
   PUBMED   11459929
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from AY180374.1.
            Summary: TAAR1 is a G protein-coupled receptor activated by trace
            amines. Trace amines are endogenous amine compounds that account
            for less than 1% of the biogenic amines in most brain regions
            (Bunzow et al., 2001 [PubMed 11723224]).[supplied by OMIM, Mar
            2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: AY180374.1 [ECO:0000332]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..339
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="6"
                     /map="6q23.2"
     Protein         1..339
                     /note="trace amine receptor 1; taR-1"
                     /product="trace amine-associated receptor 1"
                     /calculated_mol_wt="38961"
     Site            26..46
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          38..319
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          46..304
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            60..80
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            99..119
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            137..157
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            189..209
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            253..273
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            288..308
                     /note="propagated from UniProtKB/Swiss-Prot (Q96RJ0.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..339
                     /coded_by="NM_138327.1:1..1020"
                     /gene="TAAR1"
                     /gene_synonym="TA1; TAR1; TRAR1"
                     /db_xref="CCDS:CCDS5158.1"
                     /db_xref="GeneID:134864"
                     /db_xref="HGNC:HGNC:17734"
                     /db_xref="HPRD:18142"
                     /db_xref="MIM:609333"
ORIGIN
        1 mmpfchniin iscvknnwsn dvraslyslm vliilttlvg nlivivsish fkqlhtptnw
       61 lihsmatvdf llgclvmpys mvrsaehcwy fgevfckiht stdimlssas ifhlsfisid
      121 ryyavcdplr ykakmnilvi cvmifiswsv pavfafgmif lelnfkgaee iyykhvhcrg
      181 gcsvffskis gvltfmtsfy ipgsimlcvy yriyliakeq arlisdanqk lqiglemkng
      241 isqskerkav ktlgivmgvf licwcpffic tvmdpflhyi ipptlndvli wfgylnstfn
      301 pmvyaffypw frkalkmmlf gkifqkdssr cklflelss
//
